We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+25.88%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.99B
AUM Growth
+$404M
Cap. Flow
-$70.3M
Cap. Flow %
-2.35%
Top 10 Hldgs %
40.51%
Holding
78
New
15
Increased
15
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$140M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$48M
3
ABVX
Abivax
ABVX
+$43.8M
4
AMAM
Ambrx Biopharma Inc
AMAM
+$42.2M
5
TRML
Tourmaline Bio
TRML
+$36.3M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$136M
2
GPCR icon
Structure Therapeutics
GPCR
+$92.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$75.9M
4
IMVT icon
Immunovant
IMVT
+$66.2M
5
NVCR icon
NovoCure
NVCR
+$40.4M

Sector Composition

Rank Sector Weight
1 Healthcare 95.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
76
10x Genomics
TXG
$6B
– –
-182,691
Closed -$7.54M
MORF
77
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-470,647
Closed -$10.8M
PNT
78
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-2,781,565
Closed -$18.6M
1 2 3
4

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Deep Track Capital held 78 positions worth $2.99B, up 16% from $2.59B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Deep Track Capital's Q4 2023 filing shows 15 new, 15 increased, 16 reduced and 18 closed positions. Its largest new stake was argenx: 300,000 shares worth $114M. The largest sale was Jazz Pharmaceuticals, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 100% a quarter earlier.

  • Deep Track Capital's largest Q4 2023 buy was argenx: 300,000 shares worth $114M.
  • Deep Track Capital added most to Guardant Health in Q4 2023, an estimated $24.9M increase.
  • Deep Track Capital's biggest Q4 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $136M.
  • Deep Track Capital fully exited NovoCure in Q4 2023, selling an estimated $40.4M.
  • Deep Track Capital's ten largest holdings make up 41% of its $2.99B portfolio in Q4 2023.
  • Deep Track Capital opened 15 new positions and closed 18 in Q4 2023.
  • Deep Track Capital's portfolio value rose 16% quarter-over-quarter to $2.99B.

Based on Deep Track Capital's 13F filing for Q4 2023, filed 14 Feb 2024.